The impact of right coronary artery chronic total occlusion on clinical outcome of patients undergoing percutaneous coronary intervention for unprotected left main disease

Journal of the American College of Cardiology

Volumn 58, Issue 2, 2011, Pages 125-130

  Migliorini, Angela ^a   Valenti, Renato ^a   Parodi, Guido ^a   Buonamici, Piergiovanni ^a   Cerisano, Giampaolo ^a   Carrabba, Nazario ^a   Vergara, Ruben ^a   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

chronic total occlusion; left main disease; percutaneous coronary intervention

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; HIGH RISK PATIENT; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RIGHT CORONARY ARTERY CHRONIC TOTAL OCCLUSION; UNPROTECTED LEFT MAIN DISEASE;

AGED; ANGIOPLASTY; CORONARY ARTERY DISEASE; CORONARY VESSELS; CREATINE KINASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 79959786033     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.02.050     Document Type: Article

References (19)

1. M. Valgimigli, C.A.G. van Mieghem, and A.T.L. Ong Short-and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evacuated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH) Circulation 111 2005 1383 1389 (Pubitemid 40396804)
2. A. Chieffo, S.J. Park, E. Meliga, and I. Sheiban Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicenter registry Eur Heart J 29 2008 2108 2115
3. E. Meliga, H.M. Garcia-Garcia, and M. Valgimigli Longest available clinical outcome after drug-eluting stent implantation for unprotected left main coronary disease: the DELFT (Drug Eluting stent for LeFT main) Registry J Am Coll Cardiol 51 2008 2212 2219 (Pubitemid 351754998)
4. G.G. Biondi-Zoccai, M. Lotrionte, and C. Moretti A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary disease Am Heart J 155 2008 274 283
5. K.B. Seung, D.W. Park, and Y.H. Kim Stent versus coronary artery-bypass grafting for left main coronary disease N Engl J Med 358 2008 1781 1792
6. J. Mehilli, A. Kastrati, and R.A. Byrne Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease J Am Coll Cardiol 53 2009 1760 1768
7. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
8. M.C. Marie-Claude Morice, P.W. Serruys, and A.P. Kappetein Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial Circulation 121 2010 2645 2653
9. E.L. Hannan, C. Wu, and G. Walford Incomplete revascularization in the era of drug-eluting stents Impact on adverse outcomes J Am Coll Cardiol Intv 2 2009 17 25
10. P. Michel, F. Roques, S.A. Nashef EuroSCORE Project Group Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23 2003 684 687 (Pubitemid 36566559)
11. E.G. Bovill, M.L. Terrin, and D.C. Stump Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Ann Intern Med 115 1991 256 265
12. J.K. Kahn Angiographic suitability for catheter revascularization of total coronary occlusions in patients from a community hospital setting Am Heart J 126 1993 561 564 (Pubitemid 23274286)
13. J.D. Abbott, K.E. Kip, and H.A. Vlachos Recent trends in the percutaneous treatment of chronic total coronary occlusions Am J Cardiol 97 2006 1691 1696 (Pubitemid 43817852)
14. J.A. Grantham, S.P. Marso, J. Spertus, J. House, D.R. Holmes Jr, and B.D. Rutherford Chronic total occlusions angioplasty in the United States J Am Coll Cardiol Intv 2 2009 479 486
15. R.D. Christofferson, K.G. Lehmann, G.V. Martin, N. Every, J.H. Caldwell, and S.R. Kapadia Effect of chronic total coronary occlusion on treatment strategy Am J Cardiol 95 2005 1088 1091 (Pubitemid 40544315)
16. R. Valenti, A. Migliorini, and U. Signorini Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion Eur Heart J 29 2008 2336 2342
17. A. Migliorini, R. Valenti, and R. Marcucci High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease Circulation 120 2009 2214 2221
18. E.L. Hannan, M. Racz, and D.R. Holmes Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era Circulation 113 2006 2406 2412 (Pubitemid 43948048)
19. Y.H. Kim, D.W. Park, and W.J. Kim Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization J Am Coll Cardiol Intv 3 2010 612 623